Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Scientific Reports|September 1, 2023
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcomaJin-Ah Kim, Kenneth A Crawford, Piero A Spada, et al.
Endoscopy|September 29, 2005
Real-time detection of Helicobacter Pylori infection and atrophic gastritis: comparison between conventional methods and a novel device for gastric juice analysis during endoscopyA Tucci, P Tucci, M Bisceglia, et al.
Circulation|June 29, 1999
Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511AG Bilder, T Wentz, R Leadley, et al.
The European Respiratory Journal|August 6, 2016
Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centreGanesh Raghu, Ellen Morrow, Bridget F Collins, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 29, 2011
Epicardial fat thickness significantly decreases after short-term growth hormone (GH) replacement therapy in adults with GH deficiencyE Ferrante, A E Malavazos, C Giavoli, et al.
European Journal of Endocrinology|November 13, 2013
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patientsM Filopanti, A M Barbieri, G Mantovani, et al.
The Journal of Clinical Endocrinology and Metabolism|December 14, 2011
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter studyM Filopanti, L Olgiati, G Mantovani, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XAY M Choi-Sledeski, M R Becker, D M Green, et al.
International Journal of Cancer|January 26, 2017
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumorsE Peverelli, E Giardino, D Treppiedi, et al.
The Pharmacogenomics Journal|March 12, 2008
Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomasM Filopanti, A M Barbieri, A R Angioni, et al.
Pageof 24